Comparison of spastic equinovarus deformity patients’ characteristics in Group I (2 injection sites) and Group II (4 injection sites).
| Variable | Group I Mean ± SD (95% CI) | Group II Mean ± SD (95% CI) | P | Mean difference (95% CI) |
|---|---|---|---|---|
| No | 12 | 14 | ||
| Age (years) | 51 ± 8 (45.9-56.1) | 50 ± 8 (45.4-54.6) | 0.75 | 1 (-5.5-7.5) |
| Onset (months) | 6.3 ± 2.3 (4.8-7.8) | 6.2 ± 2.3 (4.9-7.5) | 0.91 | 0.10 (-1.8-1.9) |
| M0 (sec) | 34 ± 8.6 (28.3-39.7) | 36 ±12 (29.1-42.9) | 0.64 | -2 (-10.7-6.7) |
| M1 (sec) | 23 ± 6 (19.2-26.8) | 24 ± 9 (18.8-29.2) | 0.75 | -1 (-7.3-5.3) |
| M3 (sec) | 22 ± 7 (17.6-26.5) | 24 ± 8 (19.4-28.6) | 0.51 | -2 (-8.1-4.1) |
| M6 (sec) | 25 ± 7 (20.6-29.5) | 26 ± 9 (20.8-31.2) | 0.76 | -1 (-7.6-5.6) |